SEC 13F Intelligence

Versant Venture Management, LLC / GLUE

Versant Venture Management, LLC’s Monte Rosa Therapeutics Inc Position

Does Versant Venture Management, LLC own Monte Rosa Therapeutics Inc (GLUE)? Yes — 3.18M shares worth $52M (+37.00% of its 13F portfolio) as of Q1 2026, down from 4.38M shares the prior filed quarter.

Position Value
$52M
Q1 2026
Shares
3.18M
% of Portfolio
+37.00%
Quarters Held
6
currently held

Position History GLUE

Reported value by quarter
Q4 ’24: $39MQ4 ’24Q1 ’25: $26MQ1 ’25Q2 ’25: $25MQ2 ’25Q3 ’25: $42MQ3 ’25Q4 ’25: $69MQ4 ’25Q1 ’26: $52MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20263.18M$52M+37.00%
Q4 20254.38M$69M+45.49%
Q3 20255.65M$42M+19.72%
Q2 20255.65M$25M+31.04%
Q1 20255.65M$26M+43.56%
Q4 20245.65M$39M+45.22%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Versant Venture Management, LLC’s full portfolio or all institutional holders of GLUE.